Literature DB >> 11819825

Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.

J Cui1, X D Zhou, Y K Liu, Z Y Tang, M H Zile.   

Abstract

AIM: To study the abnormal expression of beta-catenin gene and its relationship ith invasiveness of primary hepatocellular carcinoma among Chinese people.
METHODS: Thirty-four hepatocellular carcinoma (HCC) specimens and adjacent para-cancerous tissues, 4 normal liver tissues were immunohistochemically stained to study subcellular distribution of beta-catenin. Semiquantitive analysis of expression of beta-catenin gene exon 3 mRNA was examined by RT-PCR and in situ hybridization. The relationship between expressions of both beta-catenin protein, mRNA and clinicopathological characteristics of HCC was also analyzed.
RESULTS: Immuno-histochemistry showed that all normal liver tissues and para-cancerous tissues examined displayed membranous type staining for beta-catenin protein, occasionally with weak expression in the cytoplasm. While 21 cases (61.8%) of HCC examined showed accumulated type in cytoplasms or nuclei. The accumulated type Labling Index (LI) of cancer tissue and para-cancerous tissue was (59.9 +/- 26.3) and (18.3 +/- 9.7) respectively (P<0.01). Higher accumulated type LI was closely related with invasiveness of HCC. Results of RT-PCR showed the beta-catenin gene exon 3 mRNA Expression Index (EI) of 34 HCCs was higher than that of para-cancerous tissue and normal liver tissue. Using in situ hybridization, the signal corresponding to beta-catenin gene exon 3 mRNA was particularly strong in cytoplasm of HCC when compared with those of para-cancerous and normal liver tissues. Over expression of beta-catenin exon 3 was also found to be correlated with high metastatic potential of HCC.
CONCLUSION: Abnormal expression of beta-catenin gene may contribute importantly to the invasiveness of HCC among Chinese people.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819825      PMCID: PMC4688669          DOI: 10.3748/wjg.v7.i4.542

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Frequent beta-catenin aberration in human hepatocellular carcinoma.

Authors:  H Fujie; K Moriya; Y Shintani; T Tsutsumi; T Takayama; M Makuuchi; S Kimura; K Koike
Journal:  Hepatol Res       Date:  2001-05-01       Impact factor: 4.288

2.  Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.

Authors:  K Endo; T Ueda; J Ueyama; T Ohta; T Terada
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

3.  Prospective study of early detection for primary liver cancer.

Authors:  B Yang; B Zhang; Y Xu; W Wang; Y Shen; A Zhang; Z Xu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.

Authors:  S Hiscox; W G Jiang
Journal:  Anticancer Res       Date:  1997 Mar-Apr       Impact factor: 2.480

5.  Phase tissue intercellular adhesion molecule-1 expression in nude mice human liver cancer metastasis model.

Authors:  Jing-Jing Sun; Xin-Da Zhou; Yin-Kun Liu; Ge Zhou
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

6.  Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma.

Authors:  Cheng-Zhi Xiao; Yi-Min Dai; Hong-Yu Yu; Jian-Jun Wang; Can-Rong Ni
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

7.  How a growth control path takes a wrong turn to cancer.

Authors:  E Pennisi
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

8.  Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.

Authors:  E Porfiri; B Rubinfeld; I Albert; K Hovanes; M Waterman; P Polakis
Journal:  Oncogene       Date:  1997-12-04       Impact factor: 9.867

9.  Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.

Authors:  A Ougolkov; M Mai; Y Takahashi; K Omote; V Bilim; A Shimizu; T Minamoto
Journal:  J Exp Clin Cancer Res       Date:  2000-09

Review 10.  Cell adhesion molecules in the development and progression of malignant melanoma.

Authors:  J P Johnson
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

View more
  11 in total

1.  Mouse hepatic neoplasm formation induced by trace level and low frequency exposure to diethylnitrosamine through β-catenin signaling pathway.

Authors:  Yu-Sang Li; Chang-Long Leng; Man-Tang Chen; Wei Kevin Zhang; Xiao-Jun Li; He-Bin Tang; Hong-Cai Shang; Li-Hua Zhu
Journal:  Toxicol Res (Camb)       Date:  2015-10-23       Impact factor: 3.524

2.  Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.

Authors:  Lian-Jun Yang; Wen-Liang Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

Review 3.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues.

Authors:  Guo-Qing Han; Cheng-Yong Qin; Rong-Hua Shu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

5.  Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.

Authors:  Xi-Jiang Zhao; Hui Li; Hua Chen; Yan-Xue Liu; Li-Hua Zhang; Su-Xiang Liu; Qing-Lai Feng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.

Authors:  Jian-Min Su; Lu Gui; Yi-Ping Zhou; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 7.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

8.  Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.

Authors:  Kimberley J Evason; James P Grenert; Linda D Ferrell; Sanjay Kakar
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

9.  Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia.

Authors:  Jian-Yong Shao; Hong-Yi Gao; Yu-Hong Li; Yu Zhang; You-Yong Lu; Yi-Xin Zeng
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

10.  Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.

Authors:  Lihong Wang; Tingjiao Liu; Yao Wang; Lei Cao; Mai Nishioka; Rodelio L Aguirre; Ayataka Ishikawa; Li Geng; Norihiko Okada
Journal:  Virchows Arch       Date:  2007-09-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.